20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway. - Wikidata - awgldk - TriplyDB

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

http://www.wikidata.org/entity/Q33636288

about

Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials.20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616.CYP4F2 (rs2108622) Gene Polymorphism Association with Age-Related Macular Degeneration.Molecular determinants of acute kidney injury.20-HETE attenuates the response of glucose-stimulated insulin secretion through the AKT/GSK-3β/Glut2 pathway.Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.20-HETE: Hypertension and Beyond

P2860

Q34338086-AC1D02C6-EF31-496F-96A8-7AA96DCDC1A7 Q35156042-409D84E0-0050-4306-9C56-A041FB866655 Q35157119-8F6923EC-8801-41EB-80A8-A734BEA06D15 Q37249828-3CB05640-FAA1-49AC-BBAC-213FD02EE2B1 Q38535781-DD14008D-8A5E-44D2-8862-331D8994249F Q38736558-A9D85302-5CC5-4AA6-9660-8069969E9E53 Q41461350-DF7B48A7-4569-4A29-B2FF-55D3442D898C Q51239324-8EE1077C-5FFF-402F-87D3-EE88BFD2C38E Q57210352-5938C22D-CF82-4E34-BEEE-0A7EF0C2DC4A

P2860

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

http://www.wikidata.org/entity/Q33636288

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

@ast

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

@en

type

label

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

@ast

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

@en

prefLabel

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

@ast

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

@en

P1433

Q33636288-6B6DA45A-05C1-47DB-81D1-FE174E40E373

P1476

Q33636288-C7FA6FDC-0D45-4147-83C5-0BF17FC2CF5B

P2093

Q33636288-0F3411EB-9F70-4912-AFDD-E0B965382BE3

Q33636288-2E853953-5E98-4033-B4FC-7AD0BF66DE8B

Q33636288-34998AF1-70B8-47FC-B0C3-04BB1FD153BB

Q33636288-79FD9481-35C3-474F-BE3B-6DD1816959EA

P2860

Q33636288-00AA959E-1814-447D-888A-EE3C22597B78

Q33636288-07FAB578-92A7-4DC3-AEB1-214F53D5C850

Q33636288-09031273-7C54-4564-94F0-6FE2D93DD129

Q33636288-0913DDA4-0729-4D85-9BC8-196EAFA3BB87

Q33636288-1269C2E2-A12C-4F8D-ACF3-2EA71AE3B3BD

Q33636288-1735C6B6-D896-4995-81BD-0925A4422111

Q33636288-1799B614-A295-4054-A4C0-9EC89941F3A1

Q33636288-20A96520-7DD5-41E9-9766-405C7C09DB52

Q33636288-33737E2D-028D-4244-8AF2-3073B16B40F5

Q33636288-38872A32-C9AD-48A4-BA13-BA638B0B7691

P304

Q33636288-3CC04A5A-B795-40FB-B203-7245A7B565BF

P31

Q33636288-F59237CA-B213-4209-AB9A-F8B72FB7214A

P356

Q33636288-B3B68547-CB8C-4C3D-93AE-702EC19A17FA

P433

Q33636288-02139F0F-AD91-4021-9D9D-EAD6CB751CF2

P478

Q33636288-7F2CCC0C-147B-49FD-A241-A36896403EB9

P577

Q33636288-9012469B-EEFB-4A1A-8174-45112DF3B115

P698

Q33636288-85DE0947-DA42-47EA-9020-79404E913FAF

P921

Q33636288-4959E519-E94E-4D2F-965B-11AD0AF1D490

P932

Q33636288-E9E53621-5D69-40EF-870B-61FDFECDF7B8

P356

P1433

Molecular Endocrinology

P1476

20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

@en

P2093

Guangrui Lai

http://www.w3.org/2001/XMLSchema#string

Jingjing Wu

http://www.w3.org/2001/XMLSchema#string

Xiaoliang Liu

http://www.w3.org/2001/XMLSchema#string

Yanyan Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11

Phosphorylation of Ser357 of rat insulin receptor substrate-1 mediates adverse effects of protein kinase C-delta on insulin action in skeletal muscle cells

Regulated transport of the glucose transporter GLUT4

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.

Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport.

Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.

Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.

20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.

20-Hydroxyeicosatetraenoic acid potentiates stretch-induced contraction of canine basilar artery via PKC alpha-mediated inhibition of KCa channel.

P304

1907-1916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/ME.2012-1139

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22918876

http://www.w3.org/2001/XMLSchema#string

P921

P932

5416963

http://www.w3.org/2001/XMLSchema#string